Amedisys Profit Margin

The latest profit margin for AMED is 6.54% as of June 2025. That compares with 4.89% in the prior-year period — up 33.7% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Amedisys's historical trend and sector peers before judging valuation or financial health.

Over the past year, AMED's profit margin moved from 4.89% to 6.54% — a 33.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Amedisys's valuation or profitability profile.

Against Healthcare companies, AMED currently prints 6.54% for profit margin, while the sector average sits near 13.76%. That is roughly 52.5% below the sector mean. Large gaps often invite a closer look at Amedisys's growth, margins, and balance sheet.

Profit Margin shows how effectively Amedisys converts resources into returns. At 6.54%, AMED may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.89% in the prior-year period — up 33.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AMED's profit margin (6.54%), review year-over-year change from 4.89%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.